Skip to main content
Signal8
Elsbree David B profile photo

David B. Elsbree

CIK: 0001292650

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

T2 Biosystems, Inc. logo
TTOO

T2 Biosystems, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • T2 Biosystems, Inc. logo
    TTOO

    T2 Biosystems, Inc.

    Nov 4, 2024
    Award(A)

    Restricted Stock Units

    Direct
    25K shares-
  • T2 Biosystems, Inc. logo
    TTOO

    T2 Biosystems, Inc.

    Sep 13, 2024
    Sale(S)
    Direct
    55 shares at avg. $2.42$133.1

1-2 of 2

David B. Elsbree files insider reports with the SEC as Director of T2 Biosystems, Inc. (TTOO). Signal8 holds 2 reported Form 4/5 transactions by David B. Elsbree since Sep 2024. The most recent reported transaction is a grant / award (Form 4 code A) in TTOO, dated Nov 4, 2024.

About Elsbree David B

Elsbree David B (SEC CIK 0001292650) files insider reports with the SEC as Director of T2 Biosystems, Inc. (TTOO).

Signal8 holds 2 ownership filings by Elsbree David B, all Form 4s, filed between Sep 17, 2024 and Jan 2, 2025. Those filings report 2 transactions, from Sep 13, 2024 to Nov 4, 2024. Signal8's Form 4 history starts in Sep 2024.

The business address on Elsbree David B's filings is in LEXINGTON, MA.

Recent filings by Elsbree David B

  • Nov 4, 2024: Grant or award of TTOO derivative securities (Form 4, code A).
  • Sep 13, 2024: Open-market sale of TTOO shares (Form 4, code S).

Other insiders filing for T2 Biosystems, Inc. (TTOO)

How to read Form 4 transaction codes